Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 2405

BillFederalSenateIn Committee
To amend title XVIII of the Social Security Act to assure pharmacy access and choice for Medicare beneficiaries.
About This Bill
Committee
Latest Action · July 20, 2023
Read twice and referred to the Committee on Finance. (text: CR S3461-3462)
Congress
118th (2023–2025)
Introduced
July 20, 2023
Cosponsors (4)
3D 1R
View PDF ↗

Summary

Highlight any text to annotate
Strengthening Pharmacy Access for Seniors Act This bill prohibits prescription drug plan (PDP) sponsors and pharmacy benefit managers from restricting access to any covered drug under the Medicare prescription drug benefit to a subset of their network pharmacies except for limited access drugs. Limited access drugs are those for which the Food and Drug Administration has restricted distribution to certain facilities or physicians or for which dispensing requires extraordinary special handling, coordination, or education that a network pharmacy cannot meet. PDP sponsors must annually report to the Centers for Medicare & Medicaid Services (1) a list of drugs that the PDP sponsor designated as limited access drugs, (2) the reasons for the designations, (3) information about relevant requirements for pharmacies with respect to these drugs, and (4) the types of pharmacies dispensing these drugs.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.